MedPath

Cold Plasma to Treat Hair Loss

Not Applicable
Completed
Conditions
Androgenetic Alopecia
Registration Number
NCT04379752
Lead Sponsor
Dr. Peter C. Friedman
Brief Summary

Self applied cold plasma activated medium used for androgenetic alopecia

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
14
Inclusion Criteria
  • diagnosis of mild-to moderate androgenetic alopecia
  • ability of applying treatment regularly
  • ability to keep in-person follow-up appointments
Exclusion Criteria
  • any inflammatory scalp condition
  • starting or discontinuing any hair loss treatments within 6 months of start date
  • allergy to any components of the carrier solution

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Presence of detectable hair growth3 months and 6 months

Presence of hair growth is observed clinically. Evaluation may include photo comparison, hair count, trichoscopy

Secondary Outcome Measures
NameTimeMethod
Adverse effects related to the treatmentthroughout study completeion, 6 months

Patients are monitored for adverse effects, including but not limited to irritation, itch, inflammation, scaling, redness, rash, peeling, blistering

Trial Locations

Locations (1)

The Skin Center Dermatology Group

🇺🇸

New City, New York, United States

The Skin Center Dermatology Group
🇺🇸New City, New York, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.